Furthermore, several effectively set up adverse prognostic markers, like U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, dropped their unfavorable influence in sufferers handled with VO. The only element that remained predictive of a shorter development-no cost survival On this cohort of patients was TP53 aberrations.112 Finally, the alternative